Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 1-1 of 1 results.
{{ selectedCountPage }} items selected on this page,{{ selectedCountPage }} item selected on this page,{{ selectedCountTotal }} item in total{{ selectedCountTotal }} items in total
Study aim:
Determining the effect of auricular acupressure on pain, quality of life and peripheral neuropathy caused by chemotherapy in elderly patients with breast cancer referred to centers affiliated to Kerman University of Medical Sciences.
Design:
A randomized controlled clinical trial, with parallel groups, without blinding
Settings and conduct:
Selection of 60 breast cancer patients in centers affiliated to Kerman University of Medical Sciences
Participants/Inclusion and exclusion criteria:
Under chemotherapy, including taxane agents. Elderly over 65 years old. Reported a score greater than five on a numerical rating scale for pain symptoms in the past week(indicating more severe than average pain). The possibility of participating in the project for four weeks. The ability to communicate and the absence of speech and hearing problems. Exclusion:12months or more have passed since the end of their chemotherapy treatment. Skin inflammation, use of hearing aids and piercings or holes in the intervention site. were undergoing chemotherapy or radiotherapy during the study period. Experienced ear acupressure within 3 months before attending Study. Metastatic cancer status. Having psychiatric diseases or other diseases that can affect this study
Intervention groups:
Ear acupressure intervention will be performed for three weeks in the intervention group, and plant seeds will be stuck on the ear for the first 5 days of each week, and then removed for 2 days to rest. In the control group, to clearly determine the effectiveness of ear acupressure, reduce bias and create blinding between the participants, Plant seeds will be used on different ear points, where these points are not related to CIPN. The questionnaire will be completed before, immediately after the end of the intervention and two weeks after the end of the intervention.
Main outcome variables:
Pain, quality of life and peripheral neuropathy